InsidersTradesSigma
Explore the detailed record of transactions filed by Fralick Celeste Rachelle, Director. Director active across 1 companies, notably Aspira Women's Health Inc.. Aggregated, 1 disclosures have been published. The latest transaction was disclosed on 31 March 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
1 of 1 declaration
Celeste Rachelle Fralick is a Director at Aspira Women's Health Inc. She contributes to the governance of the company and participates in strategic decision-making within the board.